申请人:Aisa Haji Akber
公开号:US20100087523A1
公开(公告)日:2010-04-08
Rupestonic acid derivatives are rupestonic acid derivative A- or B-type compounds, prepared through a condensation reaction from starting materials, i.e., a monomer compound of rupestonic acid and an aromatic amine or fatty amine or an organic alcohol, i.e., a fatty alcohol or an aromatic alcohol. Rupestonic acid, which is the monomer compound of sesquiterpene isolated from the plant Xinjiang
Artemisia rupestric
L., is used as a mother compound. Natural anti-virus lead compound with high activity are discovered by modifying the structure of the monomer compound of rupestonic acid. Activity results of the lead compound showed pharmaceutical application of anti-I, II flu virus and anti-I, II herpes simplex virus infection. These compounds can be used alone or in combination with one or more pharmaceutical acceptable, inert and nontoxic excipients or carries in a pharmaceutical composition.
Rupestonic acid的衍生物是通过从起始物质(即Rupestonic酸的单体化合物和芳香胺或脂肪胺或有机醇,即脂肪醇或芳香醇)进行缩合反应而制备出的Rupestonic酸衍生物A或B型化合物。Rupestonic酸是从新疆石蒿植物中分离出的倍半萜单体化合物,用作母化合物。通过修改Rupestonic酸的单体化合物的结构,发现了具有高活性的天然抗病毒前导化合物。前导化合物的活性结果显示了抗I、II型流感病毒和抗I、II型单纯疱疹病毒感染的药物应用。这些化合物可以单独使用或与一个或多个药物可接受的惰性和无毒的辅料或载体结合使用于药物组合物中。